Why the study?
Does adenovirus-mediated DDAH gene transfer prevent blood pressure elevation and reduce ADMA levels in a rat model of chronic kidney disease?
Population
Male Sprague-Dawley rat remnant kidney model representing progressive chronic kidney disease
Comparison
Adenovirus-mediated DDAH gene transfer vs Control nephrectomized rats (implied)
Design
Preclinical
Authors
Loading...
DDAH gene transfer shows promise in rat CKD models; leaves open translation to human hypertension therapy.
Does adenovirus-mediated DDAH gene transfer prevent blood pressure elevation and reduce ADMA levels in a rat model of chronic kidney disease?
Decreased DDAH levels and increased PRMT gene expression drive ADMA accumulation and hypertension in CKD, which can be prevented by DDAH gene transfer in a rat model.
Matsuguma et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: